BDX
US EQUITY
Health Care
Health Care Equipment
CIK: 10795
Becton Dickinson (BDX) Quant Factor Diagnostic & Fair Value Model
Becton Dickinson (Ticker: BDX) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$198.91
-0.75%
Latest Close (2026-10-23)
Market Cap: $54.18B
P/E Ratio: 36.3
Momentum Strength
3M / 12M
+25.16%
1M: +10.98%
12M: +5.74%
Quality (ROE)
Point-in-Time
+3.65%
Trailing Return on Equity
Technical Trend
RSI 14
79.1
SMA50: $185.37
SMA200: $169.89
Valuation Multiplier
Trailing
36.3
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
BDX trades at 36.3x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 10795 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-06 | $4.98B | $377.00M | - | $1.37 |
| 10-Q | 2025-09-30 | 2026-08-06 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-06 | $4.73B | $574.00M | - | $2.00 |
| 10-Q | 2026-03-31 | 2026-05-07 | $4.71B | -$311.00M | - | $-1.11 |
| 10-Q | 2025-03-31 | 2026-05-07 | $4.48B | $308.00M | - | $1.07 |
| 10-Q | 2025-12-31 | 2026-02-09 | $5.25B | $382.00M | $657.00M | $1.34 |
| 10-Q | 2024-12-31 | 2026-02-09 | $5.17B | $303.00M | $693.00M | $1.04 |
| 10-K | 2025-09-30 | 2025-11-25 | $21.84B | $1.68B | - | $5.82 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Becton Dickinson (BDX) valuation multiples, momentum factors, and point-in-time filing conventions.
How should BDX's current valuation multiple be interpreted? ↓
BDX trades at a trailing P/E of 36.3x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are BDX's key momentum and technical factor indicators? ↓
As of the latest close, BDX shows a 1-month return of +10.98%, 3-month return of +25.16%, and 12-month return of +5.74%, with a 14-day RSI of 79.1. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for BDX? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can BDX be incorporated into systematic factor models? ↓
BDX can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.